The Serum Metabolite Response to Diet Intervention with Probiotic Acidified Milk in Irritable Bowel Syndrome Patients Is Indistinguishable from that of Non-Probiotic Acidified Milk by 1H NMR-Based Metabonomic Analysis
The effects of a probiotic acidified milk product on the blood serum metabolite profile of patients suffering from Irritable Bowel Syndrome (IBS) compared to a non-probiotic acidified milk product was investigated using 1H NMR metabonomics. For eight？weeks, IBS patients consumed 0.4 L per day of a probiotic fermented milk product or non-probiotic acidified milk. Both diets resulted in elevated levels of blood serum l-lactate and 3-hydroxybutyrate. Our results showed identical effects of acidified milk consumption independent of probiotic addition. A similar result was previously obtained in a questionnaire-based evaluation of symptom relief. A specific probiotic effect is thus absent both in the patient subjective symptom evaluations and at the blood serum metabolite level. However, there was no correspondence between symptom relief and metabolite response on the patient level.
References
[1]
Drossman, D.A.; Camilleri, M.; Mayer, E.A.; Whitehead, W.E. AGA technical review on irritable bowel syndrome. Gastroenterology？2002, 123 (6), 2108–2131, doi:10.1053/gast.2002.37095. 12454866
[2]
Akehurst, R.; Kaltenthaler, E. Treatment of irritable bowel syndrome: A review of randomised controlled trials. Gut？2001, 48 (2), 272–282, doi:10.1136/gut.48.2.272. 11156653
[3]
Foxx-Orenstein, A. IBS—review and what’s new. MedGenMed？2006, 8 (3), 20. 17406160
[4]
Kim, H.J.; Camilleri, M.; McKinzie, S.; Lempke, M.B.; Burton, D.D.; Thomforde, G.M.; Zinsmeister, A.R. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther.？2003, 17 (7), 895–904, doi:10.1046/j.1365-2036.2003.01543.x. 12656692
[5]
Gosselink, M.P.; Schouten, W.R.; van Lieshout, L.M.; Hop, W.C.; Laman, J.D.; Ruseler-van Embden, J.G. Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis. Colon Rectum？2004, 47 (6), 876–884. 15108026
[6]
Gionchetti, P.; Rizzello, F.; Helwig, U.; Venturi, A.; Lammers, K.M.; Brigidi, P.; Vitali, B.; Poggioli, G.; Miglioli, M.; Campieri, M. Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial. Gastroenterology？2003, 124 (5), 1202–1209. 12730861
[7]
Niedzielin, K.; Kordecki, H.; Birkenfeld, B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur. J. Gastroenterol. Hepatol.？2001, 13 (10), 1143–1147, doi:10.1097/00042737-200110000-00004. 11711768
[8]
Kajander, K.; Hatakka, K.; Poussa, T.; Farkkila, M.; Korpela, R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: A controlled 6-month intervention. Aliment. Pharmacol. Ther.？2005, 22 (5), 387–394, doi:10.1111/j.1365-2036.2005.02579.x. 16128676
[9]
Kajander, K.; Myllyluoma, E.; Rajilic-Stojanovic, M.; Kyronpalo, S.S.; Rasmussen, M.; Jarvenpaa, S.S.; Zoetendal, E.G.; de Vos, W.M.; Vapaatalo, H.; Korpela, R. Clinical trial: Multispecies probiotic supplementation alleviates the symptoms of IBS and stabilises intestinal microbiota. Aliment. Pharmacol. Ther.？2007, 27 (1), 48–57. 17919270
[10]
Simren, M.; Ohman, L.; Olsson, J.; Svensson, U.; Ohlson, K.; Posserud, I.; Strid, H. Clinical trial: The effect of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome (IBS)—a randomized, double-blind, controlled study. Aliment. Pharmacol. Ther.？2010, 31 (2), 218–227. 19863495
[11]
Guyonnet, D.; Chassany, O.; Ducrotte, P.; Picard, C.; Mouret, M.; Mercier, C.H.; Matuchansky, C. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment. Pharmacol. Ther.？2007, 26 (3), 475–486, doi:10.1111/j.1365-2036.2007.03362.x. 17635382
[12]
Enck, P.; Klosterhalfen, S. The placebo response in functional bowel disorders: Perspectives and putative mechanisms. Neurogastroenterol. Motil.？2005, 17 (3), 325–331, doi:10.1111/j.1365-2982.2005.00676.x. 15916619
[13]
Pitz, M.; Cheang, M.; Bernstein, C.N. Defining the predictors of the placebo response in irritable bowel syndrome. Clin. Gastroenterol. Hepatol.？2005, 3 (3), 237–247, doi:10.1016/S1542-3565(04)00626-3. 15765443
[14]
Weljie, A.M.; Dowlatabadi, R.; Miller, B.J.; Vogel, H.J.; Jirik, F.R. An inflammatory arthritis-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy. J. Proteome Res.？2007, 6 (9), 3456–3464. 17696462
[15]
Slupsky, C.M.; Rankin, K.N.; Wagner, J.; Fu, H.; Chang, D.; Weljie, A.M.; Saude, E.J.; Lix, B.; Adamko, D.J.; Shah, S.; Greiner, R.; Sykes, B.D.; Marrie, T.J. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal. Chem.？2007, 79 (18), 6995–7004. 17702530
[16]
Holmes, E.; Loo, R.L.; Stamler, J.; Bictash, M.; Yap, I.K.; Chan, Q.; Ebbels, T.; De Iorio, M.; Brown, I.J.; Veselkov, K.A.; Daviglus, M.L.; Kesteloot, H.; Ueshima, H.; Zhao, L.; Nicholson, J.K.; Elliott, P. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature？2008, 453 (7193), 396–400. 18425110
[17]
Lenz, E.M.; Wilson, I.D. Analytical strategies in metabonomics. J. Proteome Res.？2007, 6 (2), 443–458. 17269702
[18]
Ersryd, A.; Posserud, I.; Abrahamsson, H.; Simren, M. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III. Aliment. Pharmacol. Ther.？2007, 26 (6), 953–961, doi:10.1111/j.1365-2036.2007.03422.x. 17767480
[19]
Francis, C.Y.; Morris, J.; Whorwell, P.J. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment. Pharmacol. Ther.？1997, 11 (2), 395–402. 9146781
[20]
Bax, A.; Davis, D.G. MLEV-17-Based Two-Dimensional Homonuclear Magnetization Transfer Spectroscopy. J. Magn. Reson.？1985, 65, 355–360.
[21]
Trygg, J.; Wold, S. O2-PLS, a two-block (X-Y) latent variable regression (LVR) method with an integral OSC filter. J. Chemom.？2003, 17 (1), 53–64, doi:10.1002/cem.775.
[22]
Nicholson, J.K.; Foxall, P.J.; Spraul, M.; Farrant, R.D.; Lindon, J.C. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal. Chem.？1995, 67 (5), 793–811, doi:10.1021/ac00101a004. 7762816
[23]
Fan, M. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog. Nucl. Magn. Reson. Spectrosc.？1996, 28, 161–219.
Connolly, E.; L？nnerdal, B. D(-)-Lactic acid producing bacteria—Safety to use in infant formulas. Nutrafoods？2004, 3 (3), 37–49.
[28]
Ljungh, A.; Lan, J.; Yanagisawa, N. Isolation, selection and characteristics of Lactobacillus paracasei subsp. paracasei F19. Microb. Ecol. Health Dis.？2002, 14 (1), 4–6.
[29]
Bergman, B.C.; Wolfel, E.E.; Butterfield, G.E.; Lopaschuk, G.D.; Casazza, G.A.; Horning, M.A.; Brooks, G.A. Active muscle and whole body lactate kinetics after endurance training in men. J. Appl. Physiol.？1999, 87 (5), 1684–1696. 10562610
[30]
Van Hall, G.; Calbet, J.A.; Sondergaard, H.; Saltin, B. Similar carbohydrate but enhanced lactate utilization during exercise after 9 wk of acclimatization to 5,620 m. Am. J. Physiol. Endocrinol. Metab.？2002, 283 (6), E1203–E1213. 12388157
[31]
Gladden, L.B. Lactate metabolism: A new paradigm for the third millennium. J. Physiol.？2004, 558 (1), 5–30, doi:10.1113/jphysiol.2003.058701. 15131240
[32]
Stanley, W.C.; Gertz, E.W.; Wisneski, J.A.; Neese, R.A.; Morris, D.L.; Brooks, G.A. Lactate extraction during net lactate release in legs of humans during exercise. J. Appl. Physiol.？1986, 60 (4), 1116–1120. 3084443
[33]
Kreisberg, R.A. Lactate homeostasis and lactic acidosis. Ann. Intern. Med.？1980, 92 (2), 227–237. 6766289
[34]
Eldridge, F.L.; T’So, L.; Chang, H. Relationship between turnover rate and blood concentration of lactate in normal dogs. J. Appl. Physiol.？1974, 37 (3), 316–320. 4415541
[35]
Lloyd, S.; Brocks, C.; Chatham, J.C. Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart. Am. J. Physiol. Heart Circ. Physiol.？2003, 285 (1), H163–H172. 12793977
[36]
Kelleher, J.K. Gluconeogenesis from labeled carbon: Estimating isotope dilution. Am. J. Physiol.？1986, 250 (3), E296–E305. 3953814
